Leila Thanasoulis

General Practice physician in New York, New York — also lists obesity medicine in the CMS registry.

Practice Details

Address
120 W 58th St
New York, NY 10019
Geocoded location: 40.7652, -73.9774
Taxonomy
Surgery
Credential
MD
NPPES Enumeration
Listed with NPPES since 2008
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
November 2025

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Surgery
  • General Practice
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Leila Thanasoulis is a General Practice physician in New York whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 688 Surgery practices in New York carrying this exact taxonomy in our directory.

GLP-1 access in New York, New York

Adult obesity rate
28.9%
#41 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$229/mo
Typical New York telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New York Medicaid, obesity indication

About 28.9% of New York adults have obesity (BMI 30+), ranking the state #41 of 50 (CDC BRFSS). Our directory currently lists 540 GLP-1-relevant clinics in New York. If a cash-pay route makes more sense, compounded semaglutide through New York telehealth averages about $229/mo — well below brand-name Wegovy or Zepbound.

Explore more New York options on the best New York GLP-1 providers page, browse every New York listing in the New York clinic directory.

Related Practices in New York

Other New York listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New York addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New York telehealth partners:

Featured Partners · New York

Featured GLP-1 providers serving New York

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more New York options on the New York clinic directory, our New York GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by New York obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Leila Thanasoulis's specialty taxonomy but not the specific medications it prescribes or its current service menu. Leila Thanasoulis is listed under General Practice, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 917-415-1040 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Leila Thanasoulis's primary specialty on file is General Practice, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Leila Thanasoulis is located at 120 W 58th St, New York, NY 10019. The phone number listed in the registry is 917-415-1040. Its full record is public in the CMS National Provider registry under NPI 1740425537.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Leila Thanasoulis is currently accepting new patients. Call the practice at 917-415-1040 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.